Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 27, 2011PLoS ONEOpen Access

Predicting Inactive Conformations of Protein Kinases Using Active Structures: Conformational Selection of Type-II Inhibitors

View Full Paper
Ask AI
Bookmark
Share

Authors

MXMin XuJining Traditional Chinese Medicine HospitalLYLu YuShanghai Medical College of Fudan UniversityBWBo WanCentral South University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Xu et al. (2011) studied this question.

synapsesocial.com/papers/6a700c0987f921057127724fhttps://doi.org/10.1371/journal.pone.0022644
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia2002 · 2,041 citations
  2. 2Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine Kinase2000 · 1,802 citations
  3. 3Type-II Kinase Inhibitor Docking, Screening, and Profiling Using Modified Structures of Active Kinase States2008 · 206 citations
  4. 4Solution Conformations and Dynamics of ABL Kinase-Inhibitor Complexes Determined by NMR Substantiate the Different Binding Modes of Imatinib/Nilotinib and Dasatinib2008 · 214 citations
  5. 5A Src-Like Inactive Conformation in the Abl Tyrosine Kinase Domain2006 · 325 citations